Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2014 Apr;311(16):1618-9.
doi: 10.1001/jama.2014.3325.

Acetazolamide for pseudotumor cerebri: evidence from the NORDIC trial

Affiliations
Editorial

Acetazolamide for pseudotumor cerebri: evidence from the NORDIC trial

Jonathan C Horton. JAMA. 2014 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: None reported.

Comment on

References

    1. Mann T, Keilin D. Sulphanilamide as a specific inhibitor of carbonic anhydrase. Nature. 1940;146:164–165.
    1. Roblin RO, Clapp JW. The preparation of heterocyclic sulfonamides. J Am Chem Soc. 1950;72:4890–4892.
    1. Birzis L, Carter CH, Maren TH. Effects of acetazolamide on CSF pressure and electrolytes in hydrocephalus. Neurology. 1958;8(7):522–528. - PubMed
    1. Lueck C McIlwaine G. Interventions for idiopathic intracranial hypertension. Cochrane Database Syst Rev. 2005;(3):CD003434. - PubMed
    1. The NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the Idiopathic Intracranial Hypertension Treatment Trial. JAMA. doi:10.1001/jama.2014.3312. - DOI - PMC - PubMed

Substances